According to the literature, SMA due to SMN1 mutations has an incidence of approximately 1 in 10,000 newborns [13–18] and a prevalence of approximately 1–2 per 100,000 persons [13, 19]. This evidence concerns the gene SMN1 and proximal spinal muscular atrophy.